Drug Shortage Report for APO-RIVASTIGMINE
| Report ID | 20900 |
| Drug Identification Number | 02336715 |
| Brand name | APO-RIVASTIGMINE |
| Common or Proper name | RIVASTIGMINE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RIVASTIGMINE |
| Strength(s) | 1.5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 BTL |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-10-20 |
| Actual start date | 2017-10-16 |
| Estimated end date | 2019-10-18 |
| Actual end date | 2019-10-11 |
| Shortage status | Resolved |
| Updated date | 2019-10-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v38 | 2019-10-15 | French | Compare |
| v37 | 2019-10-15 | English | Compare |
| v36 | 2019-09-20 | French | Compare |
| v35 | 2019-09-20 | English | Compare |
| v34 | 2019-07-30 | French | Compare |
| v33 | 2019-07-30 | English | Compare |
| v32 | 2019-07-30 | French | Compare |
| v31 | 2019-07-30 | English | Compare |
| v30 | 2019-06-25 | French | Compare |
| v29 | 2019-06-25 | English | Compare |
| v28 | 2019-05-06 | French | Compare |
| v27 | 2019-05-06 | English | Compare |
| v26 | 2019-03-27 | French | Compare |
| v25 | 2019-03-27 | English | Compare |
| v24 | 2018-10-19 | French | Compare |
| v23 | 2018-10-19 | English | Compare |
| v22 | 2018-10-11 | French | Compare |
| v21 | 2018-10-11 | English | Compare |
| v20 | 2018-08-20 | French | Compare |
| v19 | 2018-08-20 | English | Compare |